QUIDELORTHO CORP Amortization of Intangible Assets
QUIDELORTHO CORP (QDEL) reported Amortization of Intangible Assets of $49.00 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-07
- QUIDELORTHO CORP amortization of intangible assets for the quarter ending 2026-06-28 was $49.00M, a 2.30% increase year-over-year.
- QUIDELORTHO CORP amortization of intangible assets for the quarter ending 2026-03-29 was $46.80M, a 2.50% decline year-over-year.
- QUIDELORTHO CORP amortization of intangible assets for the quarter ending 2025-12-28 was $45.60M, a 4.80% decline year-over-year.
- QUIDELORTHO CORP amortization of intangible assets for the quarter ending 2025-09-28 was $47.70M, a 8.09% decline year-over-year.
- QUIDELORTHO CORP amortization of intangible assets for fiscal 2025 was $189.20M, a 6.98% decline from fiscal 2024.
- QUIDELORTHO CORP amortization of intangible assets for fiscal 2024 was $203.40M, a 0.68% decline from fiscal 2023.
- QUIDELORTHO CORP amortization of intangible assets for fiscal 2023 was $204.80M, a 54.57% increase from fiscal 2023.
- QUIDELORTHO CORP amortization of intangible assets for fiscal 2023 was $132.50M, a 383.58% increase from fiscal 2022.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-28 | $49.00M 10-Q · filed 2026-08-07 | $95.80M 10-Q · filed 2026-08-07 | $141.40M derived: sum of 3 quarters · filed 2026-08-07 | $189.10M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-29 | $46.80M 10-Q · filed 2026-05-06 | $92.40M derived: sum of 2 quarters · filed 2026-05-06 | $140.10M derived: sum of 3 quarters · filed 2026-05-06 | $188.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-28 | $45.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $93.30M derived: sum of 2 quarters · filed 2026-02-19 | $141.20M derived: sum of 3 quarters · filed 2026-08-07 | $189.20M 10-K · filed 2026-02-19 |
| 2025-09-28 | $47.70M 10-Q · filed 2025-11-06 | $95.60M derived: sum of 2 quarters · filed 2026-08-07 | $143.60M 10-Q · filed 2025-11-06 | $191.50M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-29 | $47.90M 10-Q · filed 2026-08-07 | $95.90M 10-Q · filed 2026-08-07 | $143.80M derived: sum of 3 quarters · filed 2026-08-07 | $195.70M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-30 | $48.00M 10-Q · filed 2026-05-06 | $95.90M derived: sum of 2 quarters · filed 2026-05-06 | $147.80M derived: sum of 3 quarters · filed 2026-05-06 | $199.70M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-29 | $47.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $99.80M derived: sum of 2 quarters · filed 2026-02-19 | $151.70M derived: sum of 3 quarters · filed 2026-02-19 | $203.40M 10-K · filed 2026-02-19 |
| 2024-09-29 | $51.90M 10-Q · filed 2025-11-06 | $103.80M derived: sum of 2 quarters · filed 2025-11-06 | $155.50M 10-Q · filed 2025-11-06 | $206.70M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $51.90M 10-Q · filed 2025-08-06 | $103.60M 10-Q · filed 2025-08-06 | $154.80M derived: sum of 3 quarters · filed 2026-02-19 | $206.20M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $51.70M 10-Q · filed 2025-05-08 | $102.90M derived: sum of 2 quarters · filed 2026-02-19 | $154.30M derived: sum of 3 quarters · filed 2026-02-19 | $205.70M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $51.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $102.60M derived: sum of 2 quarters · filed 2026-02-19 | $154.00M derived: sum of 3 quarters · filed 2026-02-19 | $204.80M 10-K · filed 2026-02-19 |
| 2023-10-01 | $51.40M 10-Q · filed 2024-11-08 | $102.80M derived: sum of 2 quarters · filed 2024-11-08 | $153.60M 10-Q · filed 2024-11-08 | $207.50M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-07-02 | $51.40M 10-Q · filed 2024-08-01 | $102.20M 10-Q · filed 2024-08-01 | $156.10M derived: sum of 3 quarters · filed 2025-02-27 | $206.60M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-04-02 | $50.80M 10-Q · filed 2024-05-09 | $104.70M derived: sum of 2 quarters · filed 2025-02-27 | $155.20M derived: sum of 3 quarters · filed 2025-02-27 | $176.20M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-01-01 | $53.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $104.40M derived: sum of 2 quarters · filed 2025-02-27 | $125.40M derived: sum of 3 quarters · filed 2025-02-27 | $132.50M 10-K · filed 2025-02-27 |
| 2022-10-02 | $50.50M 10-Q · filed 2023-11-02 | $71.50M derived: sum of 2 quarters · filed 2023-11-02 | $78.60M 10-Q · filed 2023-11-02 | $85.50M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-07-03 | $21.00M 10-Q · filed 2023-08-09 | $28.10M 10-Q · filed 2023-08-09 | $35.00M derived: sum of 3 quarters · filed 2024-08-01 | $41.90M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-04-03 | $7.10M 10-Q · filed 2023-05-04 | $14.00M derived: sum of 2 quarters · filed 2024-08-01 | $20.90M derived: sum of 3 quarters · filed 2024-08-01 | $27.70M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-01-02 | $6.90M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-01 | $13.80M derived: sum of 2 quarters · filed 2024-08-01 | $20.60M derived: sum of 3 quarters · filed 2024-08-01 | $27.40M 10-K/A · filed 2024-08-01 |
| 2021-10-03 | $6.90M 10-Q · filed 2022-11-04 | $13.70M derived: sum of 2 quarters · filed 2022-11-04 | $20.50M 10-Q · filed 2022-11-04 | |
| 2021-07-04 | $6.80M 10-Q · filed 2022-08-05 | $13.60M 10-Q · filed 2022-08-05 | ||
| 2021-01-03 | $27.30M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |